These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12053404)

  • 1. [The Therapeutic Drug Committee of German Physicians. 50 years in the service of drug safety in Germany].
    Müller-Oerlinghausen B; Tiaden JD
    Internist (Berl); 2002 Apr; 43(4):482, 485-92. PubMed ID: 12053404
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug safety and post-marketing control. Developments since the reform of the 1978 drug regulation].
    Wille H; Schönhöfer PS
    Internist (Berl); 2002 Apr; 43(4):469-70, 473-81. PubMed ID: 12053403
    [No Abstract]   [Full Text] [Related]  

  • 3. [The safety and registration of pharmaceuticals from the point of view of the medical practitioner].
    Kaiser RH
    Radiologe; 2002 Dec; 42(12):1016-24; quiz 1024-5. PubMed ID: 12602329
    [No Abstract]   [Full Text] [Related]  

  • 4. [European drug agency and drug management].
    Barfuss W
    Leber Magen Darm; 1996 Jul; 26(4):191-2. PubMed ID: 8965600
    [No Abstract]   [Full Text] [Related]  

  • 5. [Responsibilities of coordination centers for clinical studies and their status in general practice].
    Ohmann C
    Internist (Berl); 2002 Apr; 43(4):498-505. PubMed ID: 12053406
    [No Abstract]   [Full Text] [Related]  

  • 6. Germany opposes EU plans for regulating clinical trials owing to lack of ethical standards.
    Tuffs A
    BMJ; 2012 Oct; 345():e6640. PubMed ID: 23033377
    [No Abstract]   [Full Text] [Related]  

  • 7. [The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials?].
    Schwarz S; Frölich L; Striebel JP; Hennerici MG
    Dtsch Med Wochenschr; 2007 Jan; 132(3):108-12. PubMed ID: 17219346
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical Trials with Medicinal Products : Changes imposed by the new Clinical Trial Regulation].
    Sudhop T; Krafft H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):793-794. PubMed ID: 28748294
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ethical problems in planning therapy studies].
    Baltzer J
    Kinderkrankenschwester; 2013 Jun; 32(6):216-9. PubMed ID: 23822052
    [No Abstract]   [Full Text] [Related]  

  • 10. [Off-label use in psychopharmacotherapy].
    Fritze J; Schmauss M
    Nervenarzt; 2002 Aug; 73(8):796-9. PubMed ID: 12242971
    [No Abstract]   [Full Text] [Related]  

  • 11. [Responsibilities of ethics committees].
    von Bergmann K
    Med Klin (Munich); 2000 May; 95(1 Spec No):15-7. PubMed ID: 10851843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fundamental principles of clinical trials].
    Skarke C; Geisslinger G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):401-7. PubMed ID: 15830250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modification of the prescribing practice of the physician by decisions of drug committees, specialty groups and consensus conferences].
    Müller-Oerlinghausen B
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):606-10. PubMed ID: 9527451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Negative would be welcome. The question is whose brain child this is].
    Hakimi R
    MMW Fortschr Med; 2006 Nov; 148(44):8. PubMed ID: 17632867
    [No Abstract]   [Full Text] [Related]  

  • 15. [The 12th amendment to the German Drug Law. Chances and obstacles for investigator-initiated clinical trials].
    Dreier G; Marx C; Schmoor C; Maier-Lenz H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):445-52. PubMed ID: 15830256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical research with pharmaceutical agents in Germany: effects of the 12th amendment to the German Drug Law].
    Götte D; Weihrauch TR
    Internist (Berl); 2004 Jun; 45 Suppl 1():S48-54. PubMed ID: 15138642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Withdrawal of a drug from the market for safety reasons: process and communication].
    Genton A; Buclin T
    Praxis (Bern 1994); 2004 May; 93(19):797-801. PubMed ID: 15185486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the pharmaceutical industry in disseminating pharmacovigilance practice in developing countries.
    Shani S; Yahalom Z
    Food Drug Law J; 2008; 63(3):701-11. PubMed ID: 19031669
    [No Abstract]   [Full Text] [Related]  

  • 19. [Basic principles of clinical evaluation of medications].
    Cichutek K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):395-6. PubMed ID: 15830248
    [No Abstract]   [Full Text] [Related]  

  • 20. [Approval of drugs by national and European agencies--sequelae for the pharmaceutical industry].
    Zierenberg O
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):596-600. PubMed ID: 9527448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.